Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Aurobindo

- PMLiVE

Teva’s Symbicort generic backed for EU approval

AstraZeneca braces for competition to COPD drug

- PMLiVE

Actavis acquires Forest for $25bn

Ramps up its shift into speciality pharmaceuticals

- PMLiVE

Actavis ‘negotiating $25bn acquisition’ of Forest

Generic company reportedly in late-stage takeover talks

Deal Watch table for January 2014

Table listing all the major pharma mergers, acquisitions and collaborations in the past month

Pharma deals during January 2014

Deal Watch: Major pharma collaborations, acquisitions and agreements in the past month

China flag thumb

Actavis divests another Chinese interest

Reduces presence in “risky” market

- PMLiVE

Actavis sells EU generics businesses to Aurobindo

Divests operations in seven Western European countries

- PMLiVE

This month in 2000: The formation of GSK

The twenty-first century’s first ‘mega merger’

Biogen Idec building

Biogen Idec taps Sangamo for blood disorder drugs

Deal is worth up to $320m

- PMLiVE

AZ faces early competition to Nexium in the US

Korea's Hanmi and Amneal Pharmaceuticals launches first generic rival

- PMLiVE

Endo builds pain management business

Agrees $105m deal to acquire NuPathe

Deal Watch table for November 2013

Table listing all the major pharma mergers, acquisitions and collaborations in the past month

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links